TLX•benzinga•
Telix Announces That First Patient Has Been Dosed In First-In-Human ZOLAR Trial Of TLX300-CDx In Advanced Soft Tissue Sarcoma
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga